Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men

Clinica Chimica Acta

Volumn 411, Issue 1-2, 2010, Pages 53-58

  Jiang, Jieying ^a   Tang, Nelson L S ^a,b,c   Ohlsson, C ^d   Eriksson, Anna L ^d   Vandenput, Liesbeth ^d   Chan, Frank W K ^a   Ching, Jasmine K L ^a   Kwok, Anthony ^e   Orwoll, Eric ^f   Kwok, Timothy C Y ^e   Woo, Jean ^e   Leung, Ping Chung ^e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Li Ka Shing Institute of Health Sciences   (Hong Kong)

^c KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases   (China)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e Chinese University of Hong Kong   (Hong Kong)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CYP19A1; Sex steroid levels; Single nucleotide polymorphism

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; ESTRONE; TESTOSTERONE;

AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; ELDERLY CARE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL;

AGED; AROMATASE; BASE SEQUENCE; CHINA; COHORT STUDIES; DNA PRIMERS; ESTROGENS; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TESTOSTERONE;

EID: 70449521974     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.039     Document Type: Article

References (28)

1. Hsing A.W., Reichardt J.K., and Stanczyk F.Z. Hormones and prostate cancer: current perspectives and future directions. Prostate 52 (2002) 213-235
2. Severi G., Morris H.A., MacInnis R.J., et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 15 (2006) 86-91
3. Key T., Appleby P., Barnes I., and Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94 (2002) 606-616
4. Kuper H., Mantzoros C., Lagiou P., et al. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology 60 (2001) 355-360
5. Allen N.E., Reichardt J.K., Nguyen H., and Key T.J. Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. Cancer Epidemiol Biomark Prev 12 (2003) 578-581
6. Eriksson A.L., Lorentzon M., Vandenput L., et al. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94 (2009) 1033-1041
7. Haiman C.A., Riley S.E., Freedman M.L., Setiawan V.W., Conti D.V., and Le Marchand L. Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating shbg levels among postmenopausal women: the Multiethnic Cohort. J Clin Endocrinol Metab 90 (2005) 2198-2204
8. Sharp L., Cardy A.H., Cotton S.C., and Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 160 (2004) 729-740
9. Dunning A.M., Dowsett M., Healey C.S., et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96 (2004) 936-945
10. Haiman C.A., Dossus L., Setiawan V.W., et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67 (2007) 1893-1897
11. Olson S.H., Bandera E.V., and Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 165 (2007) 235-245
12. Travis R.C., Churchman M., Edwards S.A., et al. No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1, 090 British women. Cancer Epidemiol Biomark Prev 13 (2004) 2282-2284
13. Vidal O., Lindberg M.K., Hollberg K., et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A 97 (2000) 5474-5479
14. Tiidus P.M. Influence of estrogen on skeletal muscle damage, inflammation, and repair. Exerc Sport Sci Rev 31 (2003) 40-44
15. Risbridger G.P., Ellem S.J., and McPherson S.J. Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling. J Mol Endocrinol 39 (2007) 183-188
16. Travison T.G., Araujo A.B., Beck T.J., et al. Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. J Clin Endocrinol Metab 94 (2009) 853-860
17. Mellstrom D., Vandenput L., Mallmin H., et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res 23 (2008) 1552-1560
18. Dubey R.K., and Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal fluid Electrolyte Physiol 280 (2001) F365-F388
19. Dubey R.K., Tofovic S.P., and Jackson E.K. Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther 308 (2004) 403-409
20. Gennari L., Masi L., Merlotti D., et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab 89 (2004) 2803-2810
21. Peter I., Kelley-Hedgepeth A., Fox C.S., et al. Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 93 (2008) 2779-2785
22. Germer S., and Higuchi R. Single-tube genotyping without oligonucleotide probes. Genome Res 9 (1999) 72-78
23. Wang J., Chuang K., Ahluwalia M., et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques 39 (2005) 885-893
24. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
25. Bulun S.E., Takayama K., Suzuki T., Sasano H., Yilmaz B., and Sebastian S. Organization of the human aromatase p450 (CYP19) gene. Semin Reprod Med 22 (2004) 5-9
26. Bulun S.E., Sebastian S., Takayama K., Suzuki T., Sasano H., and Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86 (2003) 219-224
27. Long J.R., Kataoka N., Shu X.O., et al. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. Cancer Epidemiol Biomark Prev 15 (2006) 2115-2122
28. Hamaguchi M., Nishio M., Toyama T., et al. Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. Jpn J Clin Oncol 38 (2008) 734-742